CUSTOM RECOMBINANT PROTEIN PRODUCTION SERVICES MARKET ANALYSIS

Custom Recombinant Protein Production Services Market, By Expression System (Mammalian, Bacteria, Insect, Yeast, and Others), By End User (Research Institutes, Biotechnology and Pharmaceutical Companies, Contract Research Organizations and Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Sep 2023
Code : CMI2737
Pages :207
Formats :
Excel and PDF
Industry : Biotechnology

Market News

Global Custom Recombinant Protein Production Services Market: Key Developments

In July 2021, Atlas Antibodies, a provider of research antibodies based in Stockholm, Sweden, announced the acquisition of Evitria, a Biotechnology company. This transformative acquisition brings together a leading provider of highly validated research antibodies and a front-runner in the field of custom recombinant antibody expression.

In September 2021, Aviva Systems Biology, a company providing antibodies, immunoassay kits, and recombinant proteins for life science research, announced the launch of its new Protein on Demand semi-custom recombinant protein portfolio for life scientists conducting basic research and preclinical studies. The Protein on Demand portfolio of over 300,000 proteins allows rapid access to small- to mid-scale production of customized proteins for research teams.